CIPO Patents = 5

Forward Citations = 4

Loading Chart...

6 inventors (with patents filed for the assignee):

Thomas F White (6 out of 7 patents)

Dan Hoth (2 out of 2 patents)

Steven A Smith (1 out of 5 patents)

4. Edward F Schnipper (1 out of 16 patents)

5. Stephen M Nava (1 out of 1 patent)

6 patents: Sort by Forward Citations

1. 11628144 - Iniparib formulations and uses thereof (2023-04-18),

2. 11433075 - Methods of treating glioblastoma (2022-09-06),

3. 11433074 - Methods of treating glioblastoma (2022-09-06),

4. 9834575 - Cancer therapy (2017-12-05),

5. 9381246 - Cancer therapy (2016-07-05),

6. 8710104 - Catecholic butanes and use thereof for cancer therapy (2014-04-29),

Triact Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative therapies for neurological disorders. Our proprietary drug discovery platform enables us to rapidly identify and advance novel drug candidates. We are committed to improving the lives of patients with unmet medical needs through the development of breakthrough treatments.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

6 Patents

#641 in San Francisco, CA

#10,283 in California

#43,751 in US

San Francisco, CA, United States of America

Triact Therapeutics, Inc.